Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

ENTA Price Correlated With Financials For Enanta Pharmaceuticals

Free historical financial statements for Enanta Pharmaceuticals Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 36 quarters since 2013. Compare with ENTA stock chart to see long term trends.

ENTA Stock Compared to Quarterly

ENTA Income Statement

Revenue, Net:20317000
Revenue Per Share:0.9769
Selling, General & Admin Expense:12569000
Research & Development Expense:34796000
Total Operating Expenses:47365000
Operating Income:-27048000
Income Taxes:50000
Net Income:-26348000
Earnings Per Share, Basic:-1.27
Shares Outstanding, Basic Avg:20797491

ENTA Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:655000
Change in Accounts Receiveable:839000
Net Cash from Operations:-15534000
Net Cash from Operations Per Share:-0.7469
Net Cash from Financing Activities:2930000
Property, Plant & Equipment Purchases:1437000
Net Cash from Investing Activities:28231000
Net Change in Cash & Equivalents:15627000

ENTA Balance Sheet

Cash and Cash Equivalents:47962000
Accounts Receivable, Net:20318000
Total Current Assets:311713000
Property, Plant & Equipment, Net:6173000
Total Assets:375410000
Accounts Payable:6000000
Total Short-Term Liabilities:29827000
Total Liabilities:54076000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
3,621,795 sh
103,059 sh
3%
$187,864
$21,533
Armistice Capital, LLC
2,072,000 sh
2,000 sh
0%
$107,475
$9,626
Farallon Capital Management LLC
1,550,000 sh
 
$80,399
Vanguard Group Inc
1,476,910 sh
-39,779 sh
-3%
$76,609
$4,915
State Street Corp
1,377,417 sh
-322,011 sh
-19%
$71,447
-$8,885
Northern Trust Corp
964,407 sh
36,314 sh
4%
$50,023
-$16,038
Ra Capital Management, L.P.
896,724 sh
 
$46,513
Krensavage Asset Management, LLC
589,360 sh
-35,408 sh
-6%
$30,570
$1,037
Dimensional Fund Advisors LP
509,878 sh
-13,831 sh
-3%
$26,449
$1,693
Fairmount Funds Management LLC
469,264 sh
 
$24,341
Renaissance Technologies LLC
468,000 sh
-139,100 sh
-23%
$24,275
-$18,938
Geode Capital Management, LLC
362,981 sh
16,709 sh
5%
$18,827
$2,459
Invesco Ltd.
356,177 sh
-143,353 sh
-29%
$18,474
-$5,139
Jacobs Levy Equity Management, Inc
352,303 sh
54,771 sh
18%
$18,274
$4,210
FMR LLC
310,695 sh
-39,638 sh
-11%
$16,116
-$444
First Manhattan Co
243,718 sh
15,911 sh
7%
$12,641
$1,873
Price T Rowe Associates Inc /Md/
240,687 sh
52,344 sh
28%
$12,485
$3,582
Morgan Stanley
181,674 sh
-63,200 sh
-26%
$9,422
-$2,154
Goldman Sachs Group Inc
174,595 sh
36,239 sh
26%
$9,056
$2,516
Bank Of New York Mellon Corp
174,179 sh
6,384 sh
4%
$9,035
$1,104

Data imported from Enanta Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.